OTC meds are taking on a bigger role in asthma treatment and sufferers are reporting higher satisfaction levels with these OTCs than in the past. The 2021 Adult Patient Study of Asthma Medications is part of a continuing series of surveys designed to provide subscribers with invaluable insights into adult asthma sufferers' awareness, usage and attitudes toward prescription and non-prescription asthma medication.
Phase I - General Population Survey
Incidence of diagnosed asthma among adults
Report of asthma among other household members
Take medications for asthma
Phase II - Survey Among Adult Asthmatics Taking Medication
Asthma history, symptoms and triggers
Severity of asthma
Managing/treating asthma, including use of Rx and non-Rx medications, diet and role of physician
Brand awareness and usage, including brand switching and loyalty
Changing attitudes towards asthma
A market segmentation analysis was conducted to provide insights on how asthma medicators segment along attitudinal dimensions.
Electronic Deliverables
Summary Volume - Written analysis in PowerPoint including Key Findings, Summary and Market Segmentation.
Top-line Trends Volume - Trended top-line tables detailing findings from all questions.
Excel Tabulations - All survey questions cross-tabulated by key demographics (see below for list of variables)
Add-on Option
Respondent level data file to allow for purchaser's own analysis
Key Topics Covered:
INTRODUCTION
METHODOLOGY
KEY FINDINGS
SUMMARY OF FINDINGS
Phase I: General Population Survey
Incidence of Asthma & Treatment
Diagnosed Asthma by Demographics
Household Members With Asthma
Phase II: Survey of Adult Medicators
Section 1: Living With Asthma
Severity of Asthma
Severity of Asthma By Subgroups
Persistence & Seasonality of Asthma
Age When Asthma Was Diagnosed
Asthma Interferes With Daily Activities
Frequency of Asthma Symptoms
Asthma Symptoms Considered Most Bothersome
Asthma Related Emergency Room & Hospital Visits
Asthma Triggers
Attitudes About Living With Asthma
Section 2: Managing Asthma
Information Sources for Asthma
Type of Doctor Seen for Asthma
Medication Usage
Use of a Peak Flow Meter
Use of Rescue Inhaler
Refill of Rescue Inhaler & Number of Units
Type of Inhaler Preferred
Lifestyle Changes to Help Control Asthma
Foods That Help Reduce Asthma Symptoms
Foods & Ingredients Avoid to Lessen Asthma Symptoms
Satisfaction With Aspects of Managing Asthma
Self Assessment of Ability to Control Asthma
Challenges in Controlling Asthma
Concern About Cost of Asthma Treatment & Prevention
Attitudes About Managing Asthma
Section 3: Asthma & Allergies
Incidence of Allergies Among Medicators
How Seasonal Allergies are Treated
Section 4: Rx Brand Awareness & Usage
Awareness of Rx Asthma Medication Brands
Advertising Awareness for Rx Asthma Medication Brands
Rx Asthma Medication Brands Used
Current Usage of Rx Asthma Medication Brands
Requests for Rx Medication
Section 5: Rx Medication Usage Patterns
Number & Frequency of Prescription Medications Taken
Forms of Rx Medication Used
Satisfaction With Rx Medication
Switching to a New Prescription
Brands Discontinued Versus Switched To
Satisfaction With Current Prescription Regimen
Section 6: Non-Rx Medication Usage Patterns
Details of Non-Rx Medication Usage
Use of Non-Rx Medication Brands for Asthma
Satisfaction With Effectiveness of Non-Rx Medication
Section 7: Impact of COVID-19
Asthma Symptoms & Medication Change Since COVID-19 Outbreak
Rating of Disruption of COVID-19
Perception of How Long Until Country Will be Back to Normal
Mentor Capital, Inc. , a classic energy company, in its 2023 10-K, reported cash of $0.10 per share with no net debt versus today's share price of $0.04 per share. During 2023, the Company announced that the theoretical cash breakup value of the...
FIBRA Prologis (BMV:FIBRAPL 14), a leading owner and operator of Class-A industrial real estate in Mexico, declared today a cash distribution of Ps. 777.7 million (US$46.5 million), or Ps. 0.5892 per Certificado Bursátil Fiduciario Inmobiliario...
FIBRA Prologis (BMV:FIBRAPL 14), a leading owner and operator of Class-A industrial real estate in Mexico, today reported results for the first quarter 2024.
HIGHLIGHTS FROM THE QUARTER:
Net effective rents on rollover were 47.7 percent.Period-end...
Jericho Energy Ventures Inc. ("Jericho", "JEV" or the "Company"), a diversified energy company, is pleased to announce that it has commenced a strategic process to explore the spin-off and separate listing of its...
Southwestern Energy Company today announced the Company will release first quarter financial results on May 2, 2024 after market close, which will be available on Southwestern's website at www.swn.com.
Due to the pending merger with Chesapeake...